Skip to content
  • Tuesday, 27 October 2026
  • 10:35 pm
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Daiichi Sankyo and Merck Voluntarily Withdraw US Application for Lung Cancer Drug Ifinatamab Deruxtecan Following FDA Discussions
Pharmaceutical R&D

Daiichi Sankyo and Merck Voluntarily Withdraw US Application for Lung Cancer Drug Ifinatamab Deruxtecan Following FDA Discussions

Teuku Ryan Sep 29, 2026 0

Pharmaceutical giants Daiichi Sankyo and Merck & Co., known globally as MSD, have officially announced the voluntary withdrawal of their…

Read More
Pharmaceutical R&D

Bayer Secures FDA Accelerated Approval for Hyrnuo in Frontline HER2-Mutant Non-Small Cell Lung Cancer

Teuku Ryan Sep 11, 2026 0

Bayer has achieved a significant regulatory milestone with the US Food and Drug Administration (FDA) granting accelerated approval for its…

Read More
Pharmaceutical R&D

GSK Secures US Approval for Jideytro in ROS1-Positive Lung Cancer, Entering Competitive Market

Teuku Ryan Jul 23, 2026 0

Just days after finalizing a monumental $10.6 billion acquisition of Nuvalent, a move that significantly bolsters its oncology pipeline, GlaxoSmithKline…

Read More
Stem Cell & Regenerative Medicine

UCSF Researchers Discover the Human Lung as a Critical Site for Blood Production and Stem Cell Reservoir

Dwi Wanna Jul 16, 2026 0

The fundamental understanding of human physiology has undergone a significant shift following a groundbreaking study by researchers at the University…

Read More
Stem Cell & Regenerative Medicine

UCSF Researchers Discover the Human Lung as a Critical Site for Blood Production and Stem Cell Storage

Dwi Wanna Jul 6, 2026 0

The biological understanding of human hematopoiesis—the process through which the body manufactures blood cells—has undergone a fundamental shift following a…

Read More
Pharmaceutical R&D

ASCO 2026: Navigating the Evolving Landscape of Non-Small Cell Lung Cancer with Promising Data from Eli Lilly and Mixed Reactions for Summit/Akeso

Teuku Ryan Jun 4, 2026 0

The American Society of Clinical Oncology (ASCO) 2026, held from May 29 to June 2, 2026, served as a critical…

Read More
Laboratory Automation & Robotics

Small study suggests probiotic yogurt strain may boost immunotherapy response in lung cancer

Lana Keisha Jun 3, 2026 0

Immunotherapy has fundamentally reshaped the landscape of lung cancer treatment, offering a beacon of hope and significantly improving patient prognoses.…

Read More
Pharmaceutical R&D

ASCO 2026: Lung Cancer Landscape Ignites with Promising Bispecifics, Targeted Therapies, and Extended Survival Data

Teuku Ryan Jun 1, 2026 0

The annual American Society of Clinical Oncology (ASCO) congress, a cornerstone event for the global oncology community, convened in Chicago,…

Read More
Laboratory Automation & Robotics

Small study suggests probiotic yogurt strain may boost immunotherapy response in lung cancer

Lana Keisha May 26, 2026 0

The landscape of lung cancer treatment has undergone a significant transformation with the advent of immunotherapy, particularly checkpoint inhibitors, offering…

Read More
Stem Cell & Regenerative Medicine

Researchers Discover the Human Lung as a Major Site of Blood Production and Stem Cell Reservoir

Dwi Wanna May 22, 2026 0

For more than a century, medical textbooks and clinical practices have operated under the firm consensus that the bone marrow…

Read More

Posts pagination

1 2
FDA Approves Asahi Kasei Therapeutics Hovilpri for Refractory Mucocutaneous Herpes Simplex Virus in Immunocompromised AdultsAstrocytes and the Neuroscience of Fear: How Star-Shaped Cells Regulate Memory and Anxiety DisordersKoala Recovery: Rapid Population Growth Offers Hope for Restoring Lost Genetic DiversityEnvironmental Control of Superconductivity in Twisted Bilayer Graphene Opens New Frontiers for Quantum Electronics
The Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals PlummetJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactEliquis Loss of Exclusivity: A Pharmaceutical Patent Cliff of Historic ProportionsMEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric Growth
Merck and Moderna’s cancer vaccine is customized for each patient’s tumorAn Unbiased Look at Google Gemini Omni: Features, Costs, and Market ComparisonESMO 2026: Sacituzumab Tirumotecan Sets New Survival Benchmark in Recurrent Endometrial CancerLight-Driven Magnetism Breakthrough Promises Ultrafast, High-Density Digital Data Storage
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Merck and Moderna’s cancer vaccine is customized for each patient’s tumor
Lana Keisha Oct 27, 2026
Data Science & Bioinformatics
An Unbiased Look at Google Gemini Omni: Features, Costs, and Market Comparison
Evan Lee Salim Oct 27, 2026
Pharmaceutical R&D
ESMO 2026: Sacituzumab Tirumotecan Sets New Survival Benchmark in Recurrent Endometrial Cancer
Teuku Ryan Oct 27, 2026
Advanced Materials Science
Light-Driven Magnetism Breakthrough Promises Ultrafast, High-Density Digital Data Storage
Nila Kartika Wati Oct 27, 2026

Copyright © 2026 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ